alpha-fluoro-beta-alanine has been researched along with Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beijnen, JH; Dorlo, TPC; Huitema, ADR; Jacobs, BAW; Kurk, SA; May, AM; Molenaar-Kuijsten, L; Steeghs, N | 1 |
| Britsch, B; Herrmann, R; Hull, WE; Kunz, W; Port, RE | 1 |
2 other study(ies) available for alpha-fluoro-beta-alanine and Neoplasms
| Article | Year |
|---|---|
Worse capecitabine treatment outcome in patients with a low skeletal muscle mass is not explained by altered pharmacokinetics.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; beta-Alanine; Capecitabine; Female; Fluorouracil; Humans; Male; Middle Aged; Muscle, Skeletal; Neoplasms; Prodrugs; Sex Factors; Tomography, X-Ray Computed; Treatment Outcome | 2021 |
Metabolites of 5-fluorouracil in plasma and urine, as monitored by 19F nuclear magnetic resonance spectroscopy, for patients receiving chemotherapy with or without methotrexate pretreatment.
Topics: Aged; beta-Alanine; Blood Proteins; Chromatography, High Pressure Liquid; Female; Fluorides; Fluorouracil; Humans; Kinetics; Magnetic Resonance Spectroscopy; Male; Methotrexate; Middle Aged; Neoplasms; Protein Binding | 1988 |